Sort
48,018 grants matching “immunotherapy”
3D Models of Immunotherapy
$729,562David J Mooney · Harvard University · U01 · FY2018 · CA
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer
$729,450Goutam Chakraborty · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Targeting Immunosuppression Pathways to Enhance Brain Tumor Immunotherapy
$729,405John H Sampson · Duke University · P01 · FY2013 · CA
(PQ7)Multi-scale Analysis of Tumor Microenvironment Heterogeneity
$729,393Dean W Felsher · Stanford University · R01 · FY2017 · CA
Small molecule enhancers of tumor immunity targeting the LPA5 GPCR
$729,283Gabor J Tigyi · University Of Tennessee Health Sci Ctr · R01 · FY2025 · CA
Quantitative single-cell biomarkers of T-cells to optimize tumor immunotherapy
$729,130Navin Varadarajan · University Of Houston · R01 · FY2012 · CA
The use of chitosan for cancer vaccine delivery
$729,049John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
A NOVEL IMMUNOTHERAPY FOR PRIMARY AND METASTIC PROSTATE CANCER
$729,000University Of Southern California · · FY2011 · Department of Defense
IDENTIFYING THE DETERMINANTS OF CLINICAL RESPONSES TO PARP INHIBITORS IN OVARIAN CANCER IMMUNOTHERAPY
$728,996The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Department of the Army
Uncovering the Biology of Resistance to Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Patient-Derived Models.
$728,983Katerina Abigail Politi · Yale University · U01 · FY2023 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$728,883Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Personalized Adoptive T-cell Therapy for AML
$728,501David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2025 · CA
[18F]F-AraG as an imaging biomarker for early diagnosis and monitoring of cardiotoxicity related to doxorubicin and immune check point inhibitor therapy
$728,416Youngho Seo · University Of California, San Francisco · R01 · FY2022 · HL
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
$728,371Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2023 · CA
Engineered T cell approaches for Alzheimer's disease
$728,370Jonathan Kipnis · Washington University · R61 · FY2025 · AG
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
$728,348Jason Derek Merker · Univ Of North Carolina Chapel Hill · UG1 · FY2021 · CA
Cancer Center Support Grant
$728,250Paul A Bunn · University Of Colorado Denver · P30 · FY2007 · CA
Cancer Center Support Grant
$728,250Paul A Bunn · University Of Colorado Denver · P30 · FY2008 · CA
BIOENGINEERED ANTIBODIES IN CANCER IMAGING AND THERAPY
$728,162City Of Hope/Beckman Research Institute · P01 · FY2001 · CA
Novel Interventions Against HPV-associated Neoplasia
$728,157Paul F Lambert · University Of Wisconsin-Madison · U01 · FY2012 · CA
Molecular, Cellular and Genetic Analyses of Malignancies Associated with NF1
$728,153Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Bay Area Tumor Institute NCI Community Oncology Research Program (NCORP) Community Sites
$727,975Lisa (nmn) Bailey · Bay Area Tumor Institute · UG1 · FY2023 · CA
New therapeutics for Shiga toxin-E. coli disease.
$727,936Tom G Obrig · University Of Maryland Baltimore · U01 · FY2009 · AI
Engineered probiotic bacteria for colorectal cancer immunoprevention and interception
$727,904Nicholas Arpaia · Columbia University Health Sciences · UG3 · FY2025 · CA
Baltimore Pediatric AIDS Clinical Trials Group
$727,739Johns Hopkins University · U01 · FY2002 · AI